FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1833720160> ?p ?o ?g. }

• W1833720160 endingPage "1923" @default.
• W1833720160 startingPage "1918" @default.
• W1833720160 abstract "Islet transplantation to treat type 1 diabetes has been limited in part by toxicities of current immunosuppression and recipient humoral sensitization. Blockade of the CD28/CD80/86 and CD40/CD154 pathways has shown promise to remedy both these limitations, but translation has been hampered by difficulties in translating CD154-directed therapies. Prior CD40-directed regimens have led to prolonged islet survival, but fail to prevent humoral allosensitization. We therefore evaluated the addition of CTLA4Ig to a CD40 blockade-based regimen in nonhuman primate (NHP) alloislet transplantation. Diabetic rhesus macaques were transplanted allogeneic islets using the CD40-specific antibody 3A8, basiliximab induction, and sirolimus with or without CTLA4Ig maintenance therapy. Allograft survival was determined by fasting blood glucose levels and flow cytometric techniques were used to test for donor-specific antibody (DSA) formation. CTLA4Ig plus 3A8, basiliximab and sirolimus was well tolerated and induced long-term islet allograft survival. The addition of CTLA4Ig prevented DSA formation, but did not facilitate withdrawal of the 3A8-based regimen. Thus, CTLA4Ig combines with a CD40-specific regimen to prevent DSA formation in NHPs, and offers a potentially translatable calcineurin inhibitor-free protocol inclusive of a single investigational agent for use in clinical islet transplantation without relying upon CD154 blockade." @default.
• W1833720160 created "2016-06-24" @default.
• W1833720160 creator A5000972680 @default.
• W1833720160 creator A5003099842 @default.
• W1833720160 creator A5005364494 @default.
• W1833720160 creator A5007149390 @default.
• W1833720160 creator A5034827976 @default.
• W1833720160 creator A5036799246 @default.
• W1833720160 creator A5039115490 @default.
• W1833720160 creator A5039981770 @default.
• W1833720160 creator A5046944474 @default.
• W1833720160 creator A5056389032 @default.
• W1833720160 creator A5062306820 @default.
• W1833720160 creator A5065097406 @default.
• W1833720160 creator A5084074784 @default.
• W1833720160 creator A5087476769 @default.
• W1833720160 date "2012-07-01" @default.
• W1833720160 modified "2023-09-25" @default.
• W1833720160 title "CTLA4Ig Prevents Alloantibody Formation Following Nonhuman Primate Islet Transplantation Using the CD40-Specific Antibody 3A8" @default.
• W1833720160 cites W1484491614 @default.
• W1833720160 cites W1485526722 @default.
• W1833720160 cites W1592393060 @default.
• W1833720160 cites W1623137528 @default.
• W1833720160 cites W1674225733 @default.
• W1833720160 cites W1866506002 @default.
• W1833720160 cites W1973505502 @default.
• W1833720160 cites W1979721491 @default.
• W1833720160 cites W2002905931 @default.
• W1833720160 cites W2023492750 @default.
• W1833720160 cites W2025631961 @default.
• W1833720160 cites W2054083392 @default.
• W1833720160 cites W2074332806 @default.
• W1833720160 cites W2084034225 @default.
• W1833720160 cites W2102369007 @default.
• W1833720160 cites W2113570624 @default.
• W1833720160 cites W2118061894 @default.
• W1833720160 cites W2137780217 @default.
• W1833720160 cites W2154507669 @default.
• W1833720160 cites W2328786770 @default.
• W1833720160 doi "https://doi.org/10.1111/j.1600-6143.2012.04029.x" @default.
• W1833720160 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3387300" @default.
• W1833720160 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22458552" @default.
• W1833720160 hasPublicationYear "2012" @default.
• W1833720160 type Work @default.
• W1833720160 sameAs 1833720160 @default.
• W1833720160 citedByCount "43" @default.
• W1833720160 countsByYear W18337201602012 @default.
• W1833720160 countsByYear W18337201602013 @default.
• W1833720160 countsByYear W18337201602014 @default.
• W1833720160 countsByYear W18337201602015 @default.
• W1833720160 countsByYear W18337201602016 @default.
• W1833720160 countsByYear W18337201602017 @default.
• W1833720160 countsByYear W18337201602018 @default.
• W1833720160 countsByYear W18337201602019 @default.
• W1833720160 countsByYear W18337201602020 @default.
• W1833720160 countsByYear W18337201602022 @default.
• W1833720160 countsByYear W18337201602023 @default.
• W1833720160 crossrefType "journal-article" @default.
• W1833720160 hasAuthorship W1833720160A5000972680 @default.
• W1833720160 hasAuthorship W1833720160A5003099842 @default.
• W1833720160 hasAuthorship W1833720160A5005364494 @default.
• W1833720160 hasAuthorship W1833720160A5007149390 @default.
• W1833720160 hasAuthorship W1833720160A5034827976 @default.
• W1833720160 hasAuthorship W1833720160A5036799246 @default.
• W1833720160 hasAuthorship W1833720160A5039115490 @default.
• W1833720160 hasAuthorship W1833720160A5039981770 @default.
• W1833720160 hasAuthorship W1833720160A5046944474 @default.
• W1833720160 hasAuthorship W1833720160A5056389032 @default.
• W1833720160 hasAuthorship W1833720160A5062306820 @default.
• W1833720160 hasAuthorship W1833720160A5065097406 @default.
• W1833720160 hasAuthorship W1833720160A5084074784 @default.
• W1833720160 hasAuthorship W1833720160A5087476769 @default.
• W1833720160 hasBestOaLocation W18337201601 @default.
• W1833720160 hasConcept C126322002 @default.
• W1833720160 hasConcept C128057223 @default.
• W1833720160 hasConcept C154317977 @default.
• W1833720160 hasConcept C165220095 @default.
• W1833720160 hasConcept C202751555 @default.
• W1833720160 hasConcept C203014093 @default.
• W1833720160 hasConcept C2779234475 @default.
• W1833720160 hasConcept C2779306644 @default.
• W1833720160 hasConcept C2780252810 @default.
• W1833720160 hasConcept C2781307858 @default.
• W1833720160 hasConcept C2781413609 @default.
• W1833720160 hasConcept C2909675724 @default.
• W1833720160 hasConcept C2911091166 @default.
• W1833720160 hasConcept C39347974 @default.
• W1833720160 hasConcept C55493867 @default.
• W1833720160 hasConcept C71924100 @default.
• W1833720160 hasConcept C86803240 @default.
• W1833720160 hasConceptScore W1833720160C126322002 @default.
• W1833720160 hasConceptScore W1833720160C128057223 @default.
• W1833720160 hasConceptScore W1833720160C154317977 @default.
• W1833720160 hasConceptScore W1833720160C165220095 @default.
• W1833720160 hasConceptScore W1833720160C202751555 @default.
• W1833720160 hasConceptScore W1833720160C203014093 @default.
• W1833720160 hasConceptScore W1833720160C2779234475 @default.
• W1833720160 hasConceptScore W1833720160C2779306644 @default.

• next